New drug DF9001 targets cancer cells in early trial
NCT ID NCT05597839
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 27 times
Summary
This study tested a new drug called DF9001 in 24 adults with advanced solid tumors that have not responded to other treatments. The drug works by helping the body's immune cells recognize and attack cancer cells. The main goals were to check safety and find the best dose, both when used alone and with another immunotherapy drug (pembrolizumab).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR, ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AMR Kansas City
Kansas City, Missouri, 64114, United States
-
Banner MD Anderson
Gilbert, Arizona, 85234, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Minnesota
Rochester, Minnesota, 55905, United States
-
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
-
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
Rutgers
New Brunswick, New Jersey, 08903, United States
-
UC Irvine Medical Center
Irvine, California, 92617, United States
-
UMPC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
USC/Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Cincinnati
Cincinnati, Ohio, 45219, United States
-
University of Louisville Hospital
Louisville, Kentucky, 40202, United States
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Virginia Cancer Specialists
Fairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.